STIFEL FINANCIAL CORP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 229 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
STIFEL FINANCIAL CORP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$803,949
+14.4%
19,821
-6.8%
0.00%0.0%
Q3 2022$703,000
-7.5%
21,273
-1.4%
0.00%0.0%
Q2 2022$760,000
-24.6%
21,579
-1.5%
0.00%0.0%
Q1 2022$1,008,000
-33.1%
21,917
-3.5%
0.00%
-50.0%
Q4 2021$1,506,000
+5.5%
22,708
-0.6%
0.00%0.0%
Q3 2021$1,427,000
-24.9%
22,853
-0.4%
0.00%
-33.3%
Q2 2021$1,900,000
+27.0%
22,936
+1.7%
0.00%
+50.0%
Q1 2021$1,496,000
-12.9%
22,560
+0.8%
0.00%
-33.3%
Q4 2020$1,717,000
+77.6%
22,383
-0.4%
0.00%
+50.0%
Q3 2020$967,000
+3.2%
22,466
+3.5%
0.00%0.0%
Q2 2020$937,000
+38.8%
21,701
-7.3%
0.00%0.0%
Q1 2020$675,000
-55.6%
23,413
-2.3%
0.00%
-33.3%
Q4 2019$1,519,000
+124.0%
23,975
-0.4%
0.00%
+50.0%
Q3 2019$678,000
+5.8%
24,068
-0.1%
0.00%0.0%
Q2 2019$641,000
+42.4%
24,090
-1.5%
0.00%
+100.0%
Q1 2019$450,000
+47.1%
24,468
-0.9%
0.00%0.0%
Q4 2018$306,000
+7.4%
24,696
-53.8%
0.00%0.0%
Q2 2016$285,00053,4880.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders